Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Antonia Syrnioti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Triple-Negative Breast Cancer (TNBC) encompasses a biologically heterogeneous group of tumors, which can be classified into distinct molecular subtypes, namely basal-like 1 (BL1), basal-like 2 (BL2), immunomodulatory (IM), mesenchymal (M), mesenchymal stem-like (MSL), and luminal androgen receptor (LAR), with unique clinical and pathological characteristics. While immune features of these subtypes have been extensively characterized, the integration of non-immune stromal and structural components into our understanding of TNBC biology is only now being fully recognized. This narrative review synthesizes current evidence regarding differences in the non-immune microenvironment across TNBC molecular subtypes, with a focus on cancer-associated fibroblasts (CAFs), vascular features, extracellular matrix (ECM) dynamics, and epithelial–mesenchymal transition (EMT), along with metabolic–hypoxic reprogramming. Data from several studies are integrated to highlight subtype-specific signatures. Differences in stromal architecture and metabolic adaptations, potentially reflecting the underlying molecular heterogeneity, may hold prognostic or predictive significance and could inform personalized therapeutic strategies targeting the tumor–stroma interface.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- Department of Medical Oncology, Papageorgiou University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
- First Department of Surgery, Papageorgiou University General Hospital, School of Medicine, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
- One Brooklyn Health, Brookdale University Medical Center, Brooklyn, NY 11212, USA.
ORCID-Profile: Antonia Syrnioti, Eleni Timotheadou, Vasileios Papadopoulos, Triantafyllia Koletsa
Zitieren
APA
Syrnioti, A., Timotheadou, E., Papadopoulos, V., Syrnioti, G., & Koletsa, T. (2025). Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211211
Vancouver
Syrnioti A, Timotheadou E, Papadopoulos V, Syrnioti G, Koletsa T. Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211211
BibTeX
@article{Syrnioti2025,
author = {Syrnioti, Antonia and Timotheadou, Eleni and Papadopoulos, Vasileios and Syrnioti, Georgia and Koletsa, Triantafyllia},
title = {Dissecting the Non-Immune Tumor Microenvironment in Triple-Negative Breast Cancer: Molecular Subtype-Specific Patterns and Prognostic Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211211}
}
EUVIMED